![](images/1121bd5f74e41d905d7bb044d1f3f7163163c9a5bdc64407a8faa37b1f5cdc2c.jpg)  
FIGURE 3 -Induction of caspase-dependent apoptosis by flavopiridol in theADR clones of OS and EFTs.MNNG/ADR or WE-68/ADR cells were cultured in DMEM or RPMI 1640 medium containing  $10\%$  FBS.(a) The cells were treated with  $200\,\mathrm{\nM}$  (left panel,MNNG/ ADR)or  $160\ \mathrm{nM}$  of flavopiridol (right panel, WE-68/ADR) for the indicated time.Whole cell lysates from the treated cells were prepared and Western blot analysis was carried out using anti-caspase-9, -3, -8 and actin antibodies. (b) The ADR cells  $(2\mathrm{-}3\mathrm{~\times~}10^{3})$  wereculturedin 96-well plates for  $24~\mathrm{hr}$  and pretreated with  $0.1\%$  DMSO, pan caspase inhibitor   $\boldsymbol{Z}$  VAD-FMK),caspase-8 inhibitor (Z-IETD-FMK) or caspase-3 inhibitor (Z-DEVD-FMK) at indicated concentrations,followed byincubation with  $0.1\%$  DMSO or flavopiridol for an additional  $2\dot{4}\,\mathrm{\,hr}$  Theviabilityof cellswasmeasuredbyCellTiter-Glo Luminescent assays. (c) MNNG/ADR cells were cultured in  $60~\mathrm{mm}$  dishes for  $24~\mathrm{hr}$  The caspase inhibitors were used as described above. Whole cell lysates were prepared and subjected toWestern blot analysis using anti-PARP and caspase-3 antibodies. The data represent the means of three separate experiments performed in triplicate; bars represent SD. \*,  $p<\bar{0}.05$   $^+$  , treatment;  $-$  , no treatment.  

time-dependent manner in ADR clones of OS and EFTs, as indicated by the reduction in the intensites of proenzymes of caspase9 and caspase-3, and increase in the cleaved products of caspase-8 (Fig. 3a). Co-treatment with a broad-spectrum caspase inhibitor (Z-VAD-FMK) or a caspase-3 specific inhibitor (Z-DEVD-FMK) significantly reduced the efficacy of favopiridol on the induction of the cell death in ADR cells, but a caspase-8 specific inhibitor (Z-IETD-FMK) could not inhibit the cell death (Fig. 3b). As shown in Figure 3c,  $75~\upmu\mathrm{M}$  Z-VAD-FMKand  $50~\upmu\mathrm{M}$  Z-DEVDFMK efficiently inhibited favopiridol-induced caspase-3 activation and cleavage of PARPin MNNG/ADR cells.These results revealed that flavopiridol could induce caspase-dependent apoptosis in the drug-resistant OS and EFTs clones, and that caspase-3 inhibitor, but not caspase-8 inhibitor, could prevent the cleavage ofcaspase-3and theactivationofPARP.  

![](images/062fedc4382ee9c1ae93a3818debf9394f2f2b889a6abce7b89c56c33424aa07.jpg)  
FIGURE 4 - The apoptotic effects of flavopiridol via mitochondrial pathway in the ADR clones of OS and EFTs. (a) After the treatment of parental (P)or ADR cells of MNNG and WE-68  $\langle5\times10^{7}$  cells)with flavopiridolfor  $24~\mathrm{hr}$  ,the cytosolic extracts were obtained and subjected to Western blot analysis as described in Material and methods. Actin was used as the internal control.(b)The ADR clones of OS and EFTs were treated withvarious concentrations of flavopiridol for  $24~\mathrm{hr}$  The whole cell lysates were prepared and Western blot analysis was carried out using anti-p53,Bax,Bcl-xL,Bcl-2,and actin antibodies.  

# The apoptoticeffect of flavopiridol wasmainlymediatedby mitochondrialpathwayintheADRclonesofOSandEFTs  

We next investigated whether the activation of caspase-9 and caspase-3 were attributed to the mitochondrial injury, which could lead to release of cytochrome c. Treatments of parental and ADR clones of OS and EFTs with 400 and  $320\;\mathrm{nM}$  flavopiridolresulted in the expression of cytochrome c in the cytosolic fractions of the treated cells (Fig. 4a). It is reported that disruption of the balance between proapoptotic and antiapoptotic proteins, e.g. altered Bax/ Bcl-2 ratio, is a precursor for the release of cytochrome c from mitochondria,31 and that Bax gene is a target of p53 and can be regulated by, p53 via transcriptional-dependent2 or independent mechanisms.33 In the present study, as shown in Figure  $4b$  ,the treatmentsofMNNG/ADRandWE-68/ADRcellswithfavopiridol resulted in a decrease in the Bcl-2 and Bcl-xL expression in a dose-dependent manner. On the other hand, favopiridol dosedependently increased Bax and p53 expression in WE-68/ADR cells, but not in MNNG/ADR cells. This difference in response may relate to the difference in p53 status, which is wild-type in WE-68and mutant inMNNG.  

# Flavopiridolinhibitedthegrowthof thedrug-resistantOSand EFTstumorsinmice  

Sinceflavopiridol displayed  antiproliferativeand apoptotic effects on ADR clones of OS and EFTs in vitro, we set out to investigate the antiproliferative activity of flavopiridol in vivo.  